Identifying pre-disease signals before metabolic syndrome in mice by dynamical network biomarkers.

Journal: Scientific reports
Published Date:

Abstract

The establishment of new therapeutic strategies for metabolic syndrome is urgently needed because metabolic syndrome, which is characterized by several disorders, such as hypertension, increases the risk of lifestyle-related diseases. One approach is to focus on the pre-disease state, a state with high susceptibility before the disease onset, which is considered as the best period for preventive treatment. In order to detect the pre-disease state, we recently proposed mathematical theory called the dynamical network biomarker (DNB) theory based on the critical transition paradigm. Here, we investigated time-course gene expression profiles of a mouse model of metabolic syndrome using 64 whole-genome microarrays based on the DNB theory, and showed the detection of a pre-disease state before metabolic syndrome defined by characteristic behavior of 147 DNB genes. The results of our study demonstrating the existence of a notable pre-disease state before metabolic syndrome may help to design novel and effective therapeutic strategies for preventing metabolic syndrome, enabling just-in-time preemptive interventions.

Authors

  • Keiichi Koizumi
    Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan. kkoizumi@inm.u-toyama.ac.jp.
  • Makito Oku
    Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan. Electronic address: oku@sat.t.u-tokyo.ac.jp.
  • Shusaku Hayashi
    Division of Gastrointestinal Pathophysiology, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
  • Akiko Inujima
    Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
  • Naotoshi Shibahara
    Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
  • Luonan Chen
    Key Laboratory of Systems Health Science of Zhejiang Province, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou, 310024, China.
  • Yoshiko Igarashi
    First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, 930-0194, Japan.
  • Kazuyuki Tobe
    First Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, 2630 Sugitani, Toyama, 930-0194 Japan.
  • Shigeru Saito
    Department of Obstetrics and Gynecology, University of Toyama, Toyama City, Japan.
  • Makoto Kadowaki
    Division of Gastrointestinal Pathophysiology, Institute of Natural Medicine, University of Toyama, Toyama, 930-0194, Japan.
  • Kazuyuki Aihara
    Collaborative Research Center for Innovative Mathematical Modelling, Institute of Industrial Science, University of Tokyo, Japan.